[(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine

C84H94BBrCl2N18O15S3 — CID 167563194

IUPAC[(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine
SMILESCOc1cc(-n2cnc(N)c2)cc(OC)c1OC.COc1cc(-n2cnc(Nc3nc(N4CCC[C@H]4CO)c4ccc(-c5cccc(NS(C)(=O)=O)c5)cc4n3)c2)cc(C)c1C.CS(=O)(=O)Nc1cccc(-c2ccc3c(N4CCC[C@H]4CO)nc(Cl)nc3c2)c1.CS(=O)(=O)Nc1cccc(B(O)O)c1.OC[C@@H]1CCCN1c1nc(Cl)nc2cc(Br)ccc12
InChIInChI=1S/C32H35N7O4S.C20H21ClN4O3S.C13H13BrClN3O.C12H15N3O3.C7H10BNO4S/c1-20-13-26(16-29(43-3)21(20)2)38-17-30(33-19-38)35-32-34-28-15-23(22-7-5-8-24(14-22)37-44(4,41)42)10-11-27(28)31(36-32)39-12-6-9-25(39)18-40;1-29(27,28)24-15-5-2-4-13(10-15)14-7-8-17-18(11-14)22-20(21)23-19(17)25-9-3-6-16(25)12-26;14-8-3-4-10-11(6-8)16-13(15)17-12(10)18-5-1-2-9(18)7-19;1-16-9-4-8(15-6-11(13)14-7-15)5-10(17-2)12(9)18-3;1-14(12,13)9-7-4-2-3-6(5-7)8(10)11/h5,7-8,10-11,13-17,19,25,37,40H,6,9,12,18H2,1-4H3,(H,34,35,36);2,4-5,7-8,10-11,16,24,26H,3,6,9,12H2,1H3;3-4,6,9,19H,1-2,5,7H2;4-7H,13H2,1-3H3;2-5,9-11H,1H3/t25-;16-;9-;;/m000../s1
InChIKeyDXWHLIDMMNOOOT-KWEIZXMASA-N
MW1853.61 g/mol
LogP11.69
Rot. Bonds23

About [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine

[(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine (PubChem CID 167563194) has the molecular formula C84H94BBrCl2N18O15S3 and a molecular weight of 1853.61 g/mol. Its IUPAC name is [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine.

Molecular Properties

Compound Name[(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine
PubChem CID167563194
Molecular FormulaC84H94BBrCl2N18O15S3
Molecular Weight1853.61 g/mol
Exact Mass1850.50
IUPAC Name[(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine
SMILESCOc1cc(-n2cnc(N)c2)cc(OC)c1OC.COc1cc(-n2cnc(Nc3nc(N4CCC[C@H]4CO)c4ccc(-c5cccc(NS(C)(=O)=O)c5)cc4n3)c2)cc(C)c1C.CS(=O)(=O)Nc1cccc(-c2ccc3c(N4CCC[C@H]4CO)nc(Cl)nc3c2)c1.CS(=O)(=O)Nc1cccc(B(O)O)c1.OC[C@@H]1CCCN1c1nc(Cl)nc2cc(Br)ccc12
InChIInChI=1S/C32H35N7O4S.C20H21ClN4O3S.C13H13BrClN3O.C12H15N3O3.C7H10BNO4S/c1-20-13-26(16-29(43-3)21(20)2)38-17-30(33-19-38)35-32-34-28-15-23(22-7-5-8-24(14-22)37-44(4,41)42)10-11-27(28)31(36-32)39-12-6-9-25(39)18-40;1-29(27,28)24-15-5-2-4-13(10-15)14-7-8-17-18(11-14)22-20(21)23-19(17)25-9-3-6-16(25)12-26;14-8-3-4-10-11(6-8)16-13(15)17-12(10)18-5-1-2-9(18)7-19;1-16-9-4-8(15-6-11(13)14-7-15)5-10(17-2)12(9)18-3;1-14(12,13)9-7-4-2-3-6(5-7)8(10)11/h5,7-8,10-11,13-17,19,25,37,40H,6,9,12,18H2,1-4H3,(H,34,35,36);2,4-5,7-8,10-11,16,24,26H,3,6,9,12H2,1H3;3-4,6,9,19H,1-2,5,7H2;4-7H,13H2,1-3H3;2-5,9-11H,1H3/t25-;16-;9-;;/m000../s1
InChIKeyDXWHLIDMMNOOOT-KWEIZXMASA-N
XLogP11.69
TPSA437.33 Ų
H-Bond Donors10
H-Bond Acceptors30
Rotatable Bonds23
Heavy Atoms124
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001853.61
LogP ≤ 511.69
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine?
The IUPAC name of [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine (CID 167563194) is [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine.
What is the SMILES notation for [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine?
The canonical SMILES for [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine is COc1cc(-n2cnc(N)c2)cc(OC)c1OC.COc1cc(-n2cnc(Nc3nc(N4CCC[C@H]4CO)c4ccc(-c5cccc(NS(C)(=O)=O)c5)cc4n3)c2)cc(C)c1C.CS(=O)(=O)Nc1cccc(-c2ccc3c(N4CCC[C@H]4CO)nc(Cl)nc3c2)c1.CS(=O)(=O)Nc1cccc(B(O)O)c1.OC[C@@H]1CCCN1c1nc(Cl)nc2cc(Br)ccc12.
What is the InChIKey of [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine?
The InChIKey is DXWHLIDMMNOOOT-KWEIZXMASA-N. The full InChI is InChI=1S/C32H35N7O4S.C20H21ClN4O3S.C13H13BrClN3O.C12H15N3O3.C7H10BNO4S/c1-20-13-26(16-29(43-3)21(20)2)38-17-30(33-19-38)35-32-34-28-15-23(22-7-5-8-24(14-22)37-44(4,41)42)10-11-27(28)31(36-32)39-12-6-9-25(39)18-40;1-29(27,28)24-15-5-2-4-13(10-15)14-7-8-17-18(11-14)22-20(21)23-19(17)25-9-3-6-16(25)12-26;14-8-3-4-10-11(6-8)16-13(15)17-12(10)18-5-1-2-9(18)7-19;1-16-9-4-8(15-6-11(13)14-7-15)5-10(17-2)12(9)18-3;1-14(12,13)9-7-4-2-3-6(5-7)8(10)11/h5,7-8,10-11,13-17,19,25,37,40H,6,9,12,18H2,1-4H3,(H,34,35,36);2,4-5,7-8,10-11,16,24,26H,3,6,9,12H2,1H3;3-4,6,9,19H,1-2,5,7H2;4-7H,13H2,1-3H3;2-5,9-11H,1H3/t25-;16-;9-;;/m000../s1.
What are the key properties of [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine?
[(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine has a molecular weight of 1853.61 g/mol, XLogP of 11.69, 23 rotatable bonds, 10 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-1-(7-bromo-2-chloroquinazolin-4-yl)pyrrolidin-2-yl]methanol;N-[3-[2-chloro-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]quinazolin-7-yl]phenyl]methanesulfonamide;N-[3-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-[[1-(3-methoxy-4,5-dimethylphenyl)imidazol-4-yl]amino]quinazolin-7-yl]phenyl]methanesulfonamide;[3-(methanesulfonamido)phenyl]boronic acid;1-(3,4,5-trimethoxyphenyl)imidazol-4-amine is sourced from PubChem (CID 167563194), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).